[go: up one dir, main page]

NO311802B1 - Nye karboksylsyre-derivater og deres anvendelse - Google Patents

Nye karboksylsyre-derivater og deres anvendelse Download PDF

Info

Publication number
NO311802B1
NO311802B1 NO19984713A NO984713A NO311802B1 NO 311802 B1 NO311802 B1 NO 311802B1 NO 19984713 A NO19984713 A NO 19984713A NO 984713 A NO984713 A NO 984713A NO 311802 B1 NO311802 B1 NO 311802B1
Authority
NO
Norway
Prior art keywords
alkyl
carboxylic acid
acid derivatives
crc4
endothelin
Prior art date
Application number
NO19984713A
Other languages
English (en)
Norwegian (no)
Other versions
NO984713L (no
NO984713D0 (no
Inventor
Wilhelm Amberg
Andreas Kling
Dagmar Klinge
Hartmut Riechers
Ernst Baumann
Liliane Unger
Manfred Raschack
Stefan Hergenroeder
Sabine Schult
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO984713L publication Critical patent/NO984713L/no
Publication of NO984713D0 publication Critical patent/NO984713D0/no
Publication of NO311802B1 publication Critical patent/NO311802B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
NO19984713A 1996-04-12 1998-10-09 Nye karboksylsyre-derivater og deres anvendelse NO311802B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614542A DE19614542A1 (de) 1996-04-12 1996-04-12 Neue Carbonsäurederivate, ihre Herstellung und Verwendung
PCT/EP1997/001687 WO1997038982A1 (de) 1996-04-12 1997-04-04 Neue carbonsäurederivate, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
NO984713L NO984713L (no) 1998-10-09
NO984713D0 NO984713D0 (no) 1998-10-09
NO311802B1 true NO311802B1 (no) 2002-01-28

Family

ID=7791123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984713A NO311802B1 (no) 1996-04-12 1998-10-09 Nye karboksylsyre-derivater og deres anvendelse

Country Status (23)

Country Link
US (1) US6103732A (de)
EP (1) EP0892788A1 (de)
JP (1) JP2000508325A (de)
KR (1) KR20000005366A (de)
CN (1) CN1216042A (de)
AR (1) AR006593A1 (de)
AU (1) AU711293B2 (de)
BG (1) BG63202B1 (de)
BR (1) BR9708614A (de)
CA (1) CA2250764A1 (de)
CO (1) CO4900038A1 (de)
DE (1) DE19614542A1 (de)
HR (1) HRP970200A2 (de)
ID (1) ID19050A (de)
IL (1) IL126026A0 (de)
NO (1) NO311802B1 (de)
NZ (1) NZ331704A (de)
PL (1) PL329240A1 (de)
SK (1) SK127698A3 (de)
TR (1) TR199802042T2 (de)
TW (1) TW419465B (de)
WO (1) WO1997038982A1 (de)
ZA (1) ZA973096B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000057642A (ko) * 1996-12-18 2000-09-25 스타르크, 카르크 헤테로시클릭 카르복실산 유도체, 그의 제제 및 엔도텔린 수용체길항제로서의 용도
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
CN1269792A (zh) * 1997-09-04 2000-10-11 Basf公司 新羧酸衍生物,它们的制备方法和作为混合eta/etb受体拮抗药的用途
CA2306216C (en) * 1997-10-17 2011-06-07 Eurogene Limited The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
EP1243262B1 (de) * 2001-03-20 2006-05-31 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
EP1243263B1 (de) * 2001-03-21 2002-11-27 Schwarz Pharma Ag Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
EA013591B1 (ru) 2004-04-16 2010-06-30 Шварц Фарма Аг Применение пептидных соединений для профилактики, облегчения и лечения головной боли и болезненных состояний, связанных с или вызванных распространяющейся кортикальной депрессией (csd)
PL1781276T3 (pl) * 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
EP1754476A1 (de) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
AU2007260207B2 (en) * 2006-06-15 2012-11-08 Ucb Pharma Gmbh Pharmaceutical composition with synergistic anticonvulsant effect

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411225A1 (de) * 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel
AU2882195A (en) * 1994-06-27 1996-01-19 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides

Also Published As

Publication number Publication date
KR20000005366A (ko) 2000-01-25
BG63202B1 (bg) 2001-06-29
BR9708614A (pt) 1999-08-03
EP0892788A1 (de) 1999-01-27
AU2636497A (en) 1997-11-07
JP2000508325A (ja) 2000-07-04
PL329240A1 (en) 1999-03-15
HRP970200A2 (en) 1998-04-30
DE19614542A1 (de) 1997-10-16
CA2250764A1 (en) 1997-10-23
AU711293B2 (en) 1999-10-07
WO1997038982A1 (de) 1997-10-23
TW419465B (en) 2001-01-21
ID19050A (id) 1998-06-04
SK127698A3 (en) 2000-03-13
IL126026A0 (en) 1999-05-09
CN1216042A (zh) 1999-05-05
US6103732A (en) 2000-08-15
TR199802042T2 (xx) 2000-09-21
NO984713L (no) 1998-10-09
AR006593A1 (es) 1999-09-08
BG102770A (en) 1999-11-30
ZA973096B (en) 1998-10-12
CO4900038A1 (es) 2000-03-27
NO984713D0 (no) 1998-10-09
NZ331704A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
NO310497B1 (no) Pyrimidin- eller triazin-karboksylsyrederivater, hvilke kan anvendes som legemidler
NO311802B1 (no) Nye karboksylsyre-derivater og deres anvendelse
NO311025B1 (no) Aminosyrederivater, legemiddel inneholdende dem og anvendelse som endotelinantagonister
NO311801B1 (no) Nye hydroksykarboksylsyre-derivater og deres anvendelse
NO311571B1 (no) Nye karboksylsyre-derivater og deres anvendelse
CA2307770A1 (en) Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists
NO313519B1 (no) Heterocykliske karboksylsyre-derivater, preparater inneholdende dem, og anvendelse av dem til fremstilling av slikepreparater
CA2294050A1 (en) New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
TW546295B (en) Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB receptor antagonists
HUP0100957A2 (hu) [(5-Szubsztituált-2-pirimidinil)-oxi]-karbonsav-származékok, előállításuk, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
EP1037883A1 (de) NEUE HETEROCYCLISCH SUBSTITUIERTE $g(a)-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN
CA2379545A1 (en) Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
CA2375666A1 (en) Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
HRP20000650A2 (en) Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et<->a<p>/et<->b<p> receptor antafonists
MXPA00006463A (en) 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
CZ2000743A3 (cs) Deriváty kyseliny karboxylové a jejich použití
CZ20002963A3 (cs) Nové deriváty karboxylové kyseliny, obsahující 5- substituovaný pyrimidinový kruh, jejich příprava a použiti
MXPA00001479A (en) Novel carboxylic acid derivatives, their production and their use as mixed eta
CZ20003219A3 (cs) Nové nesymetricky subtituované deriváty karboxylových kyselin, jejich přípravy a použití jako smíšených antagonistů ETA/ETB receptorů
MXPA00007417A (en) Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta
CZ20001788A3 (cs) Heterocyklický substituované deriváty kyseliny alfa-hydroxykarboxylové,jejich výroba a použití
DE19809376A1 (de) Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2003